Utah Medical Prod (UTMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,645 | 3,856 | 1,969 | 10,220 | 8,823 |
| Depreciation Amortization | 514 | 349 | 178 | 809 | 616 |
| Income taxes - deferred | -330 | 24 | 91 | 75 | 137 |
| Accounts receivable | 49 | -469 | -116 | -226 | -14 |
| Accounts payable and accrued liabilities | 138 | 145 | -90 | 312 | 179 |
| Other Working Capital | -1,395 | -1,857 | -761 | 15,953 | 16,282 |
| Other Operating Activity | -8 | 428 | 161 | 316 | 238 |
| Operating Cash Flow | $4,613 | $2,476 | $1,432 | $27,459 | $26,261 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -286 | -230 | -127 | -411 | -351 |
| Net Acquisitions | N/A | N/A | N/A | -1,012 | -1,012 |
| Purchase Of Investment | -4,100 | -3,300 | -2,100 | -22,103 | -22,103 |
| Sale Of Investment | 7,202 | 5,760 | 1,168 | 8,202 | 4,248 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -10 | -10 |
| Other Investing Activity | 0 | 0 | 1 | -10 | -10 |
| Investing Cash Flow | $2,816 | $2,230 | $-1,058 | $-15,334 | $-19,228 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 646 | 541 | 131 | 1,111 | 1,055 |
| Common Stock Repurchased | -6,551 | -5,218 | -1,140 | -10,698 | -6,143 |
| Dividend Paid | -1,842 | -1,230 | -616 | -1,331 | -678 |
| Other Financing Activity | 1 | -1 | 0 | 0 | -1 |
| Financing Cash Flow | $-7,746 | $-5,908 | $-1,625 | $-10,918 | $-5,767 |
| Exchange Rate Effect | 10 | 9 | 4 | -151 | -3 |
| Beginning Cash Position | 1,818 | 1,818 | 1,818 | 762 | 762 |
| End Cash Position | 1,511 | 626 | 571 | 1,818 | 2,024 |
| Net Cash Flow | $-307 | $-1,193 | $-1,247 | $1,056 | $1,262 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,613 | 2,476 | 1,432 | 27,459 | 26,261 |
| Capital Expenditure | -286 | -230 | -127 | -411 | -351 |
| Free Cash Flow | 4,327 | 2,246 | 1,305 | 27,048 | 25,910 |